An elderly woman with asthma, eosinophilia, and septic shock

Cleveland Clinic Journal of Medicine

Volumn 74, Issue 12, 2007, Pages 877-886

  Kabirdas, Deepa ^a   Afonso, Bianca ^a   Avella, Hernan ^a   Kanwar, Aarti ^a   Berho, Mariana ^a   Oliveira, Eduardo ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; TIABENDAZOLE;

AGED; ANIMAL; ASTHMA; CASE REPORT; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA; FEMALE; HUMAN; ISOLATION AND PURIFICATION; REVIEW; SEPTIC SHOCK; STRONGYLOIDES; STRONGYLOIDIASIS;

AGED; ANIMALS; ANTI-BACTERIAL AGENTS; ASTHMA; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FEMALE; HUMANS; SHOCK, SEPTIC; STRONGYLOIDES; STRONGYLOIDIASIS; THIABENDAZOLE;

EID: 38949198822     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.74.12.877     Document Type: Review

References (44)

1. Weiss ST, Speizer FE. Epidemiology and natural history In: Weiss EB, Stein M, editors. Bronchial Asthma: Mechanisms and Therapeutics, 3rd ed. Boston: Little, Brown, 1993:15-25.
2. Wood RA, Phlpatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy, J Allergy Clin Immunol 1999; 103:773-779.
3. Sears MR, Burrows B, Flannery EM, Herbison GP, Hewitt CJ, Holdaway MD. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children. N Engl J Med 1991; 325:1067-1071.
4. Weller PF. Eosinophilia in travelers. Med Clin North Am 1992; 76:1413-1432.
5. Sablé-Fourtassou R, Cohen P, Mahr A, et al. French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143:632-638.
6. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990; 33:1074-1087.
7. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995; 13:193-198.
8. Stevens DA, Moss RB, Kurup VP, et al; Participants in the Cystic Fibrosis Foundation Consensus Conference. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37(suppl 3):S225-S264.
9. Wilson ME, Weller PF. Eosinophilia. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical Infectious Diseases: Principles, Pathogens, and Practice, 2nd ed. Philadelphia: Elsevier Churchill Livingstone, 2006:1478.
10. Gelpi AP, Mustafa A. Ascaris pneumonia. Am J Med 1968; 44:377-389.
11. Sen P, Gil C, Estrellas B, Middleton JR. Corticosteroid-induced asthma: a manifestation of limited hyperinfection syndrome due to Strongyloides stercoralis. South Med J 1995; 88: 923-927.
12. Wehner JH, Kirsch CM, Kagawa Fr, Jensen WA, Campagna AC, Wilson M. The prevalence and response to therapy of Strongyloides stercoralis in patients with asthma from endemic areas. Chest 1994, 106:762-766.
13. Liebow AA. The J. Burns Amberson lecture - pulmonary angiitis and granulomatosis. Am Rev Respir Dis 1973; 108:1-18.
14. Koss MN, Robinson RG, Hochholzer L. Bronchocentric granulomatosis. Hum Pathol 1981; 12:632-638.
15. Clee MD, Lamb D, Clark RA. Bronchocentric granulomatosis: a review and thoughts on pathogenesis. Br J Dis Chest 1983; 77:227-234.
16. Sithithaworn J, Sithithaworn P, Janrungsopa T, Suvatanadecha K, Ando K, Haswell-Elkins MR. Comparative assessment of the gelatin particle agglutination test and an enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. J Clin Microbiol 2005; 43:3278-3282.
17. Carroll SM, Karthigasu KT, Grove DI. Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg 1981; 75:706-709.
18. Schaffel R, Nucci M, Carvalho E, et al. The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. Am J Trop Med Hyg 2001; 65:346-350.
19. Rosenblatt JE. Clinical importance of adequately performed stool ova and parasite examinations. Clin Infect Dis 2006; 42:979-980.
20. Dreyer G, Fernandes-Silva E, Alves S, Rocha A, Albuquerque R, Addiss D. Patterns of detection of Strongyloides stercoralis in stool specimens: implications for diagnosis and clinical trials. J Clin Microbiol 1996; 34:2569-2571.
21. Smith B, Verghese A, Guiterrez C, Dralle W, Berk SL. Pulmonary strongyloidiasis. Diagnosis by sputum gram stain. Am J Med 1985; 79:663-666.
22. Harris RA Jr, Musher DM, Fainstein V, Young EJ, Clarridge J. Disseminated strongyloidiasis: diagnosis made by sputum examination, JAMA 1980; 244:65-66.
23. Neva FA, Gam AA. Maxwell C, Pelletier LL. Skin test antigens for immediate hypersensitivity prepared from infective larvae of Strongyloides stercoralis. Am J Trop Med Hyg 2001, 65.567-572.
24. Nwokolo C, Imohiosen EA. Strongyloidiasis of respiratory tract presenting as 'asthma'. Br Med J 1973; 2:153-154.
25. Newberry AM, Williams DN, Stauffer WM, Boulware DR, Hendel-Patterson BR, Walker PF. Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 2005; 128:3681-3684.
26. Keiser PB, Nutman TB. Strongy1oldes stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-217.
27. El Masry HZ, O'Donnell J. Fatal Strongyloides hyperinfection in heart transplantation. J Heart Lung Transplant 2005; 24:1980-1983.
28. Siddiqui AA, Genta RM, Berk SL. Strongyloidiasis, Chap 111, In: Guerrant RL, Walter DH, Weller PF, editors. Tropical Infectious Diseases: Principles, Pathogens, and Practice. Philadelphia: Elsevier Churchill Livingstone, 2006:1274.
29. Lin AL, Kessimian N, Benditt JO. Restrictive pulmonary disease due to interlobular septal fibrosis associated with disseminated infection by Strongyloides stercoralis. Am J Respir Crit Care Med 1995; 151:205-209.
30. Lessnau KD, Can S, Talavera W. Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature. Chest 1993; 104:119-122.
31. Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patiehts receiving corticosteroids. N Engl J Med 1966; 275:1093-1096.
32. Longworth DL, Weller PF. Hyperinfection syndrome with strongyloidiasis. In: Remington JS, Swartz MN, editors. Current Clinical Topics in Infectious Diseases. New York: McGraw-Hill, 1986:1.
33. Woodring JH, Halfhill H II, Reed JC. Pulmonary strongyloidiasis: clinical and imaging features. AJR Am J Roentgenol 1994; 162:537-542.
34. Pacanowski J, Santos MD, Roux A. et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005; 73:122-124.
35. Tarr PE, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003; 68:453-455.
36. Salluh JJ, Feres GA, Velasco E, Holanda GS, Toscana, L, Soares M. Successful Ose of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis an septic shock. Intensive Care Med 2005; 31:1292.
37. Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sánchez-Sánchez P, Matogo-Oyana J, Rodriguez-Calabuig D. Efficacy and safety of ivermectin and thiabenclazole in the treatment of strongyloidiasis. Expert Opin Pharmaccither 2004; 5:2615-2619.
38. Zaha O, Hirata T, Kinjo F, Saito A, Fukuhara H. Efficacy of ivermectin for chronic strongyloidiasis: two sing!e doses given 2 weeks apart. J Infect Chemother 2002; 8:94-98.
39. Marti H, Haji HJ, Savioli L. et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996; 55:477-481.
40. Beus A. [Comparative study of thiabendazole and mebendazole in Strongyloidlasis]. [In Croatian.] Lijec Vjesn 1989; 111:98-101.
41. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. Am J Trop Med Hyg 2002; 66:749-752.
42. Karunajeewa H, Kelly H, Leslie D, Leydon J, Saykao P, Biggs BA. Parasite-specific IgG response and peripheral blood eosinophil count following albendazole treatment for presumed chronic strongyloidiasis. J Travel Med 2006; 13:84-91.
43. Stemmermann GN. Strongyloidiasis in migrants. Pathological and clinical considerations. Gastroenterology 1967; 53:59-70.
44. Jantz MA, Sahn SA. Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med 1999; 160:1079-1100.